- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05517681
Application of ICG in Lymph Node Dissection During Radical Resection of Rectal Cancer With Preserved Autonomic Nerves Around LCA and IMA
August 24, 2022 updated by: The First Hospital of Qinhuangdao
Indocyanine green NIR imaging is valuable for lymph node dissection in D3 radical surgery for rectal cancer.
It can guide the intraoperative improvement of lymph node dissection based on the preservation of LCA and peripheral autonomic nerves of IMA.
This not only reduces the occurrence of postoperative complications and promotes rapid postoperative recovery, but also provides a more precise and individualized comprehensive treatment plan for patients after surgery.
In addition,this trial also demonstrated that ICG is safe and feasible for use in rectal cancer
Study Overview
Detailed Description
The pathological data of 96 patients with rectal cancer from September 2020 - July 2022 were collected from the First Hospital of Qinhuangdao City.In 51 of these patients, ICG was injected preoperatively via anoscope or anal dilator in the mucosal layer around the tumor, and surgical treatment was performed after visualization.
The surgical approach was performed by laparoscopic radical rectal cancer with an intermediate approach step.The IMA root is treated with low ligation of the IMA, while lymph node dissection is performed while preserving the autonomic nerves around the IMA.
The other 45 patients were not injected with ICG, and the procedure was performed as before.The occurrence of postoperative complications was recorded, and the detection of lymph nodes was also compared between the two groups, as well as the intraoperative situation and postoperative recovery.
Study Type
Interventional
Enrollment (Actual)
96
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Qinhuangdao, China
- The First hosptial of Qinhuangdao
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
38 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The preoperative colonoscopic pathological diagnosis was clearly rectal cancer and no malignant tumor in other sites.
- Good preoperative general condition, no serious cardiopulmonary, hepatic, renal or other major comorbidities before surgery
- Radical rectal cancer surgery with preservation of LCA and peripheral autonomic nerves of IMA in patients
- No contraindications to surgery
- No history of ICG or iodide allergy
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: non-ICG Group
Laparoscopic radical resection of rectal cancer was performed routinely without ICG injection
|
Laparoscopic radical resection of rectal cancer was performed routinely without ICG injection.
The separation should extend from the center to the left, reaching the left paracolic sulcus lateral to the genital vessels.
The Superior hypogastric nerve is protected by freeing it at the angle of the common iliac artery on both sides, afterwards, the vessel is free along the surface of the plexus from caudal to cephalic side to reach the root of the IMA.
Switching lymph node visualization patterns.
Based on the operator's experience and the extent of lymph node visualization, the lymph nodes at the root of the IMA were removed with an ultrasonic knife .
The dissection continues caudally along the IMA, preserving the arterial sheath.
Expose the left colonic artery, superior rectal artery, and sigmoid artery, maximum preservation of the IMA peripheral plexus while clearing their surrounding lymph nodes.
|
Experimental: ICG Group
ICG was injected preoperatively via anoscope or anal dilator in the mucosal layer around the tumor, and surgical treatment was performed after visualization.
The surgical approach was performed by laparoscopic radical rectal cancer with an intermediate approach step.The IMA root is treated with low ligation of the IMA, while lymph node dissection is performed while preserving the autonomic nerves around the IMA
|
Dilute ICG to 2.5 mg/ml with its accompanying sterilized water for injection.
Slow injection with a 1ml syringe in 4 parts of the tumor,Inject 0.25ml per site .
Procedure started after lymph node visualization.The operation was consistent with the control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The number of cleared IMA root lymph nodes
Time Frame: immediately after surgery
|
A group of lymph nodes surrounding the inferior mesenteric artery between the origin of the artery and the left colic artery
|
immediately after surgery
|
The total number of cleared lymph nodes
Time Frame: immediately after surgery
|
The sum of IMA root lymph nodes and lymph nodes surrounding the tumor area
|
immediately after surgery
|
The number of positive lymph nodes
Time Frame: immediately after surgery
|
There are metastatic tumor cells in the lymph nodes
|
immediately after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of postoperative recovery
Time Frame: Up to 7 days after surgery
|
days of postoperative hospitalization, days of retention of the urinary catheter, days of retention of abdominal drainage tube, time of first fluid intake and IPSS score
|
Up to 7 days after surgery
|
The incidence of postoperative complications
Time Frame: Up to 7 days after surgery
|
mild or severe urogenital disorders, anastomotic leakage, anastomotic bleeding, abdominal infection, intestinal obstruction.
|
Up to 7 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: liuhanchong Hanchong Liu, The First Hospital of Qinhuangdao
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 7, 2020
Primary Completion (Actual)
July 10, 2022
Study Completion (Actual)
July 10, 2022
Study Registration Dates
First Submitted
August 23, 2022
First Submitted That Met QC Criteria
August 24, 2022
First Posted (Actual)
August 26, 2022
Study Record Updates
Last Update Posted (Actual)
August 26, 2022
Last Update Submitted That Met QC Criteria
August 24, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20210130
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Indocyanine Green
-
Jilin UniversityUnknownEndoscopic Submucosal Injection of Indocyanine GreenChina
-
Indonesia UniversityCompletedPerfusion | Free Flap Evaluation | Indocyanine Green ConcentrationIndonesia
-
Indonesia UniversityActive, not recruitingTemperature Change, Body | Indocyanine Green | Microsurgery | Free FlapIndonesia
-
University Hospital Inselspital, BerneCompletedEndometriosis | Laparoscopy | Near Infrared Fluorescence Imaging | Indocyanine Green (ICG)Switzerland
-
Castilla-La Mancha Health ServiceCompletedPostoperative Complications | Acute Liver Failure | Indocyanine Green
-
Cancer Institute and Hospital, Chinese Academy...RecruitingIndocyanine Green | Fluorescence | Rectal Cancer SurgeryChina
-
Fujian Medical UniversityCompletedStomach Neoplasms | Indocyanine GreenChina
-
Shandong Linglong Yingcheng HospitalRecruitingIndocyanine Green | Total Thyroidectomy | Parathyroid Function Low Adverse Event | Parathyroid Glands--DiseasesChina
-
Fujian Medical University Union HospitalRecruitingEsophageal Cancer | Indocyanine GreenChina
-
Fujian Medical UniversityActive, not recruitingGastric Cancer | Indocyanine Green | Injection SiteChina
Clinical Trials on non-ICG
-
Huazhong University of Science and TechnologyUnknownCervical Cancer | Sentinel Lymph NodeChina
-
Kaiser PermanenteNot yet recruitingProstate Cancer | Lymphocele
-
University of PennsylvaniaCompleted
-
Third Affiliated Hospital, Sun Yat-Sen UniversityUnknown
-
Pulsion Medical Systems SEUnknownMalignant Neoplasm of BreastGermany
-
Activ SurgicalRecruitingCholecystitis | Biliary Dyskinesia | CholelithiasisUnited States
-
Huazhong University of Science and TechnologyUnknown
-
Huazhong University of Science and TechnologyUnknown
-
Chang Gung Memorial HospitalUnknownFluorenscent Image Guided Surgery | Indocyanide GreenTaiwan
-
National Taiwan University HospitalTaiwanese Osteoposis Association, Wang Jhan-Yang Charitable Trust FundCompletedOsteoporosis FractureTaiwan